John Frater
John Frater
Verified email at ndm.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
14042021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
11422020
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, ...
Nature medicine 13 (1), 46-53, 2007
11232007
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ...
Journal of Crohn's and Colitis 3 (2), 47-91, 2009
6162009
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5142009
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
4592020
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
4042020
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ...
Nature 568 (7751), 244-248, 2019
3412019
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
2952021
Early and nonreversible decrease of CD161++/MAIT cells in HIV infection
C Cosgrove, JE Ussher, A Rauch, K Gärtner, A Kurioka, MH Hühn, ...
Blood, The Journal of the American Society of Hematology 121 (6), 951-961, 2013
2922013
HIV-1 DNA predicts disease progression and post-treatment virological control
JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ...
elife 3, e03821, 2014
2692014
European Crohn’s and Colitis Organisation (ECCO)
JF Rahier, F Magro, C Abreu, A Armuzzi, S Ben-Horin, Y Chowers, ...
Second European evidence-based consensus on the prevention, diagnosis and …, 2014
2352014
Selection bias at the heterosexual HIV-1 transmission bottleneck
JM Carlson, M Schaefer, DC Monaco, R Batorsky, DT Claiborne, J Prince, ...
Science 345 (6193), 2014
2332014
Short-course antiretroviral therapy in primary HIV infection
SPARTAC Trial Investigators
New England Journal of Medicine 368 (3), 207-217, 2013
2132013
Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy
AJ Frater, DT Dunn, AJ Beardall, K Ariyoshi, JR Clarke, MO McClure, ...
Aids 16 (8), 1139-1146, 2002
1542002
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
J Hurst, M Hoffmann, M Pace, JP Williams, J Thornhill, E Hamlyn, ...
Nature communications 6 (1), 1-9, 2015
1312015
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression
AJ Frater, H Brown, A Oxenius, HF Gunthard, B Hirschel, N Robinson, ...
Journal of virology 81 (12), 6742-6751, 2007
1262007
Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients
AJ Frater, A Beardall, K Ariyoshi, D Churchill, S Galpin, JR Clarke, ...
Aids 15 (12), 1493-1502, 2001
1262001
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
1222020
Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline,‘definetherain’
M Jones, J Williams, K Gärtner, R Phillips, J Hurst, J Frater
Journal of virological methods 202, 46-53, 2014
1222014
The system can't perform the operation now. Try again later.
Articles 1–20